However, although the metabolic efficacy of these emerging agents is clear, their long-term cardiovascular safety profiles remain speculative until the conclusion of ongoing phase 3 trials (Wharton et al., 2025)
here's why it might be a bad idea Kourtney Kardashian is expanding her wellness empire with a new product alternative to GLP-1 medications like Ozempic
A Research Letter published in 2022, which utilized FDA data, definitively demonstrated that individuals using Ozempic have a significantly heightened risk of developing gallstones and acute gallbladder disease
Prevalence of Graves Disease Varies Widely by Race/Ethnicity
Its primary role is to regulate blood sugar levels by stimulating insulin release and inhibiting glucagon
Joint problems Patients who start losing weight on GLP-1s often experience less joint pain at first but after a few months, Ortiz-Pujols said their aches sometimes start creeping back